TABLE 4.

Treatment outcomes for participants finishing follow-up as part of therapeutic efficacy monitoring in Angola in 2019

Outcome	No. of participants (%)
	Benguela		Zaire		Lunda Sul
	AL (n = 101)	ASAQ (n = 98)	AL (n = 95)	ASAQ (n = 91)	AL (n = 95)	ASAQ (n = 99)
Treatment failure	10 (10)	0	16 (17)	14 (15)	14 (15)	0
Early treatment failure	0	0	0	1 (1)	0	0
Recurrent parasitemia	10 (10)	0	16 (17)	13 (14)	14 (15)	0
Recrudescence	1 (1)	0	8 (8)	3 (3)	12 (13)	0
Day 14	1 (1)	0	1 (1)	0	2 (2)	0
Day 21	0	0	5 (5)	1 (1)	9 (9)	0
Day 28	0	0	2 (2)	2 (2)	1 (1)	0
Reinfection	9 (9)	0	8 (8)	10 (11)	2 (2)	0
Day 14	0	0	1 (1)	1 (1)	2 (2)	0
Day 21	3 (3)	0	2 (2)	5 (5)	0	0
Day 28	6 (6)	0	5 (5)	4 (4)	0	0
Adequate clinical and parasitological response	91 (90)	98 (100)	79 (83)	77 (85)	81 (85)	99 (100)